Proinsulin-transferrin fusion protein as a novel long-acting insulin analog for the inhibition of hepatic glucose production.
about
Fusion Proteins for Half-Life Extension of Biologics as a Strategy to Make BiobettersInsulin analogues in type 1 diabetes mellitus: getting better all the time.Half-life extended biotherapeutics.Pursuit of a perfect insulin.Tissue barriers and novel approaches to achieve hepatoselectivity of subcutaneously-injected insulin therapeutics.Characterization and Oral Delivery of Proinsulin-Transferrin Fusion Protein Expressed Using ExpressTec.
P2860
Proinsulin-transferrin fusion protein as a novel long-acting insulin analog for the inhibition of hepatic glucose production.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 18 December 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Proinsulin-transferrin fusion ...... of hepatic glucose production.
@en
Proinsulin-transferrin fusion ...... of hepatic glucose production.
@nl
type
label
Proinsulin-transferrin fusion ...... of hepatic glucose production.
@en
Proinsulin-transferrin fusion ...... of hepatic glucose production.
@nl
prefLabel
Proinsulin-transferrin fusion ...... of hepatic glucose production.
@en
Proinsulin-transferrin fusion ...... of hepatic glucose production.
@nl
P2093
P2860
P356
P1433
P1476
Proinsulin-transferrin fusion ...... of hepatic glucose production.
@en
P2093
Jennica L Zaro
Juntang Shao
Wei-Chiang Shen
P2860
P304
P356
10.2337/DB13-0973
P407
P577
2013-12-18T00:00:00Z